These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10420153)

  • 1. Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates.
    Gann PH; Klein KG; Chatterton RT; Ellman AE; Grayhack JT; Nadler RB; Lee C
    Prostate; 1999 Sep; 40(4):248-55. PubMed ID: 10420153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and transforming growth factor alpha concentrations in BPH and cancer of the prostate: their relationships with tissue androgen levels.
    Yang Y; Chisholm GD; Habib FK
    Br J Cancer; 1993 Jan; 67(1):152-5. PubMed ID: 7678977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
    Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
    Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor-related peptides in human prostatic fluid: sources of variability in assay results.
    Gann PH; Chatterton R; Vogelsong K; Grayhack JT; Lee C
    Prostate; 1997 Sep; 32(4):234-40. PubMed ID: 9288181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
    Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
    Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasia.
    Wolff JM; Fandel T; Borchers H; Brehmer B; Jakse G
    Br J Urol; 1998 Mar; 81(3):403-5. PubMed ID: 9523660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 3 is expressed in nondividing basal epithelial cells in normal human prostate and benign prostatic hyperplasia, and is no longer detectable in prostate carcinoma.
    Djonov V; Ball RK; Graf S; Mottaz AE; Arnold AM; Flanders K; Studer UE; Merz VW
    Prostate; 1997 May; 31(2):103-9. PubMed ID: 9140123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
    Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
    Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative effects of EGF, FGF, and TGF-β1 in prostate stromal cells are different from responses to single growth factors.
    Hennenberg M; Schreiber A; Ciotkowska A; Rutz B; Waidelich R; Strittmatter F; Stief CG; Gratzke C
    Life Sci; 2015 Feb; 123():18-24. PubMed ID: 25529149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-beta expression in prostate neoplasia.
    Cardillo MR; Petrangeli E; Perracchio L; Salvatori L; Ravenna L; Di Silverio F
    Anal Quant Cytol Histol; 2000 Feb; 22(1):1-10. PubMed ID: 10696454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of transforming growth factor-alpha, epidermal growth factor receptor and c-erbB-2 protein in hyperplastic human prostates.
    Giri DK; Pal R; Wadhwa SN; Talwar GP
    Carcinogenesis; 1995 Apr; 16(4):729-33. PubMed ID: 7537180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of transforming growth factor-beta 1 in patients with benign and malignant prostatic diseases.
    Wolff JM; Fandel TH; Borchers H; Jakse G
    Anticancer Res; 1999; 19(4A):2657-9. PubMed ID: 10470214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma.
    Kim ED; Smith ND; Grayhack JT
    J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative plasma levels of transforming growth factor beta(1) (TGF-beta(1)) strongly predict progression in patients undergoing radical prostatectomy.
    Shariat SF; Shalev M; Menesses-Diaz A; Kim IY; Kattan MW; Wheeler TM; Slawin KM
    J Clin Oncol; 2001 Jun; 19(11):2856-64. PubMed ID: 11387358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines.
    Jones HE; Eaton CL; Barrow D; Dutkowski CM; Gee JM; Griffiths K
    Prostate; 1997 Mar; 30(4):219-31. PubMed ID: 9111599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia?
    Di Silverio F; Sciarra A; Monti S; Casale P; Seccareccia F
    J Urol; 1999 Jan; 161(1):128-32. PubMed ID: 10037384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.